Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Nosocomial bloodstream infections are important causes of morbidity and mortality. In this study, concurrent surveillance for nosocomial bloodstream infections at 49 hospitals over a 3-year period detected >10,000 infections. Gram-positive organisms accounted for 64% of cases, gram-negative organisms accounted for 27%, and 8% were caused by fungi. The most common organisms were coagulase-negative staphylococci (32%), Staphylococcus aureus (16%), and enterococci (11%). Enterobacter, Serratia, coagulase-negative staphylococci, and Candida were more likely to cause infections in patients in critical care units. In patients with neutropenia, viridans streptococci were significantly more common. Coagulase-negative staphylococci were the most common pathogens on all clinical services except obstetrics, where Escherichia coli was most common. Methicillin resistance was detected in 29% of S. aureus isolates and 80% of coagulase-negative staphylococci. Vancomycin resistance in enterococci was species-dependent--3% of Enterococcus faecalis strains and 50% of Enterococcus faecium isolates displayed resistance. These data may allow clinicians to better target empirical therapy for hospital-acquired cases of bacteremia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Candida species are the fourth most common cause of hospital-acquired bloodstream infections (BSI) in the United States (5, 9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
In the citing paper
“These species proportions are very similar to those previously reported from the northeastern United States (9).”
In the citing paper
“The National Epidemiology of Mycoses Survey study demonstrated geographic variations in species distributions throughout the United States, with C. albicans ranging from 46% in the northeast to 70% in the southwest and C. glabrata ranging from 15% in the southwest to 26% in the northeast (9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984 · cited 3×
“Nonetheless, prospective surveillance projects such as ours will allow rapid detection of such infections, which initially appeared in Japan [17, 18] and have been reported in the United States [19].”
BackgroundHiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00192-2 · Cited by 424 · cited 1×
“Several subprojects have evaluated samples of organisms from this study and have included validation measures, such as reidentification of species and retesting of antimicrobial susceptibilities in the Special Microbiology Laboratory at the University of Iowa College of Medicine [6–14].”
BackgroundSelf-citationPfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00240-x · Cited by 331
Self-citationCeftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United States
Burwen, D. R., Banerjee, S. N., Gaynes, R. P., & System, T. N. N. I. S. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.6.1622 · Cited by 214
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
Ena, J. (1993) · JAMA · doi:10.1001/jama.269.5.598 · Cited by 203
Jones, R. N., Marshall, S. A., Pfaller, M. A., Wilke, W. W., Hollis, R. J., Erwin, M. E., Edmond, M. B., & Wenzel, R. P. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00115-6 · Cited by 153
Self-citationMarshall, S. A., Wilke, W. W., Pfaller, M. A., & Jones, R. N. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00212-5 · Cited by 146
Self-citationAntimicrobial Resistance: Issues and Options
(1998) · National Academies Press eBooks · doi:10.17226/6121 · Cited by 129
Cited by
Items 901–1,000 of 1,001
Iman, M., Davood, A., Gebbink, R. J. M. K., Azerang, P., Alibolandi, M., & Sardari, S. (2014) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-014-1140-5 · Cited by 14
Experimental superficial candidiasis on tissue models
Jayatilake, J. A. M. S., & Samaranayake, L. P. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01879.x · Cited by 14
Homology modeling of lanosterol 14α-demethylase of Candida albicans and insights into azole binding
Iman, M., & Davood, A. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0769-z · Cited by 14
Structural Analysis of a Fungal Methionine Synthase with Substrates and Inhibitors
Ubhi, D. K., Kago, G., Monzingo, A. F., & Robertus, J. D. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.02.006 · Cited by 14
Dynamics of CaCdc10, a septin of Candida albicans, in living cells and during infection.
González‐Novo, A., Jiménez, J., García, M. J., Ríos-Serrano, I., Plá, J., Jiménez, A., & Sánchez‐Pérez, M. (2004) · Estudis Romànics (Institut d'Estudis Catalans) · Cited by 14
Daptomycin and tigecycline: a review of clinical efficacy in the antimicrobial era
Ziglam, H. M. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.14.2279 · Cited by 14
Lautenbach, E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit505 · Cited by 14
Exploration of Medicinal Plants as Sources of Novel Anticandidal Drugs
Kumar, A., Khan, F., & Saikia, D. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191025155856 · Cited by 13
Antifungal activity of Cinnamaldehyde derivatives against fluconazole-resistant Candida albicans
Long, Y., Xu, J., Hu, Z., Fan, X., & Wang, H. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106877 · Cited by 13
Maddox, S. M., Coburn, P. S., Shankar, N., & Conway, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034398 · Cited by 13
Niazy, A. A., & Hughes, L. E. (2015) · Current Microbiology · doi:10.1007/s00284-015-0826-6 · Cited by 13
Les antifongiques dans le traitement des infections invasives
Carle, S. (2003) · Pharmactuel · Cited by 13
Wang, T., Hung, C., Shie, S., Chou, P.-C., Kuo, C. S., Chung, F., Lo, Y.-L., & Lin, S. (2016) · Medicine · doi:10.1097/md.0000000000003834 · Cited by 13
Ghorai, P., Irfan, M., Narula, A., & Datta, A. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9303-z · Cited by 13
Gaona, M. A., Cifuentes, G., Inés, D., Chaparro, R., Cristina, M. L., Serrato, P., Clemencia, A., Peña, P., Ibáñez‐Pinilla, M., & Gutiérrez, G. R. (2009) · Revista Ciencias de la Salud · Cited by 13
Candida albicans Biofilm Chip (CaBChip) for High-throughput Antifungal Drug Screening
Srinivasan, A., Lopez-Ribot, J. L., & Ramasubramanian, A. K. (2012) · Journal of Visualized Experiments · doi:10.3791/3845 · Cited by 13
Ubhi, D. K., Kavanagh, K. L., Monzingo, A. F., & Robertus, J. D. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.06.002 · Cited by 13
de Melo, D. O., & Ribeiro, E. (2009) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702009000300001 · Cited by 13
Rocha‐Gracia, R. D. C., Arroyo, M. M. H., Lozano-Zaraín, P., Hernández, B., Romero, H. S., Cedillo‐Portugal, E., Pérez, M. T. Z., & Olguín, J. F. L. (2011) · AFRICAN JOURNAL OF BIOTECHNOLOGY · Cited by 13
Functional Genomics Approaches for the Identification and Validation of Antifungal Drug Targets
Backer, M. D. D., Dijck, P. V., & Luyten, W. H. M. L. (2002) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200202020-00004 · Cited by 13
‘Superbugs’: new antibacterials in the pipeline
Bush, K., Macielag, M. J., & Clancy, J. (2000) · Emerging Drugs · doi:10.1517/14728214.5.4.347 · Cited by 13
Reno, J., Doshi, S., Tunali, A., Stein, B., Farley, M. M., Ray, S. M., & Jacob, J. T. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.185 · Cited by 13
Staphylococcus aureus Endocarditis: The Grady Memorial Hospital Experience
Sherwood, M. W., Smith, D. T., Crisel, R., Lerakis, S., & Veledar, E. (2006) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200602000-00014 · Cited by 13
Jacoby, T. S. (2008) · Americanae (AECID Library) · Cited by 13
A Comprehensive Review of Identification Methods for Pathogenic Yeasts: Challenges and Approaches
Morovati, H., Kord, M., Ahmadikia, K., Eslami, S., Hemmatzadeh, M., Kurdestani, K. M., Khademi, M., & Darabian, S. (2023) · Advanced Biomedical Research · doi:10.4103/abr.abr_375_22 · Cited by 12
Kamel, N. A., Soliman, M. M., Abo-Zeid, M. A., & Shaaban, M. I. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.792741 · Cited by 12
Garg, S., Naidu, J., Singh, S., Nawange, S. R., Jharia, N., & Saxena, M. (2006) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2006.07.004 · Cited by 12
Inhibition of Candida albicans growth by brominated furanones
Duo, M., Zhang, M., Luk, Y., & Ren, D. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2174-6 · Cited by 12
LAS BUENAS PRÁCTICAS DE MANIPULACIÓN DE ALIMENTOS EN EL HOSPITAL
Lorenzo, T. D., & Gálvez, M. C. (2015) · Revista Cubana de Alimentación y Nutrición · Cited by 12
Evaluating of fungal contamination in hospital wet cooling systems in Markazi province, Central Iran
Mosayebi, M., Eslamirad, Z., Hajihossein, R., Ghorbanzadeh, B., Shahverdi, M., & Didehdar, M. (2017) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2017.04.003 · Cited by 12
Xu, Z., Li, J., Zhou, X., Dai, J., Zhang, J., Huang, Y., & Xu, N. (2019) · Medical Science Monitor · doi:10.12659/msm.912971 · Cited by 12
Lambiase, A., Pezzo, M. D., Piazza, O., Petagna, C., Luca, C. D., & Rossano, F. (2007) · Infection · doi:10.1007/s15010-007-6288-4 · Cited by 12
Espectro y factores de riesgo de la infección fúngica invasora
Castón, J. J., Román, A. R., & Torre‐Cisneros, J. (2007) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13108710 · Cited by 12
Raman, S. B., Nguyen, M. H., Cheng, S., Badrane, H., Iczkowski, K. A., Wegener, M., Gaffen, S. L., Mitchell, A. P., & Clancy, C. J. (2013) · Infection and Immunity · doi:10.1128/iai.00743-12 · Cited by 12
DisseminatedCryptococcus neoformansvar.grubiiinfections in intensive care units
Chuang, Y.-H., Ku, S., Liaw, S., WU, S. C., Ho, Y., Yu, C., & Hsueh, P. (2009) · Epidemiology and Infection · doi:10.1017/s0950268809990926 · Cited by 12
Westwater, C., Balish, E., WARNER, T. F. C. S., Nicholas, P. J., Paulling, E. E., & Schofield, D. A. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47110-0 · Cited by 12
Marques, N., Sá, R., Coelho, F., da Cunha, S., & Meliço-Silvestre, A. A. (2007) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702007000500016 · Cited by 12
ENTEROCOCCAL AND VIRIDANS STREPTOCOCCAL INFECTIONS
English, B. K., & Shenep, J. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50100-x · Cited by 12
Effects of tigecycline and daptomycin on murine gut colonization by Candida albicans
Samonis, G., Mantadakis, E., Barbounakis, E., Kofteridis, D. P., Papadakis, G., Sifaki, L., & Maraki, S. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01500.x · Cited by 12
Noskin, G. A. (2001) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v30n3p320 · Cited by 12
Farina, C., Russello, G., Andreoni, S., Bonetti, C., Conte, M., Fazi, P., Lombardi, G., Luzzaro, F., Manso, E., Marone, P., et al. (2012) · Medical Mycology · doi:10.3109/13693786.2011.648216 · Cited by 11
la Cruz-Hernández, I. D., Cornejo‐Juárez, P., Tellez-Miranda, O., Barrera-Pérez, L., Sandoval, S., Vilar‐Compte, D., Velázquez-Acosta, C., & Volkow-Fernández, P. A. (2019) · American Journal of Infection Control · doi:10.1016/j.ajic.2019.06.008 · Cited by 11
Candida Biofilms : Development, Architecture, and Resistance
Chandra, J., & Mukherjee, P. K. (2015) · ASM Press eBooks · doi:10.1128/9781555817466.ch6 · Cited by 11
Khzam, A., Saunier, J., Guilbaud, M., Herry, J., Dazzi, A., Tortolano, L., Carpentier, L., Mignot, A., & Yagoubi, N. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213281 · Cited by 11
Bolden, S., Zhu, X. Y., Etukala, J. R., Boateng, C. A., Mazu, T. K., Flores‐Rozas, H., Jacob, M. R., Khan, S. I., Walker, L., & Ablordeppey, S. Y. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.09.044 · Cited by 11
Manivannan, P., & Muralitharan, G. (2014) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-014-0189-x · Cited by 11
Kalantar, E., Assadi, M., Poormazaheri, H., Hatami, S., Barari, M., Asgari, E., Mahmoudi, E., Kabir, K., & Marashi, S. M. A. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.24.10933 · Cited by 11
Incidence des bactériémies et fongémies aux hôpitaux universitaires de Strasbourg de 2005 à 2007
Bourneton, O., Mutel, T., Heranney, D., Hernandez, C., Lavigne, T., Waller, J., Jaulhac, B., & Foeglé, J. (2009) · Pathologie Biologie · doi:10.1016/j.patbio.2009.07.028 · Cited by 11
Ramos, A., Romero, Y., Sánchez‐Romero, I., Fortün, J., Paño, J. R., Pemán, J., Gurguí, M., Rodríguez‐Baño, J., & Padilla, B. (2016) · Mycoses · doi:10.1111/myc.12516 · Cited by 11
de Sá, N. P., Pôssa, A. P., Pérez, P., Ferreira, J. M. S., Fonseca, N. C., Lino, C. I., Cruz, L. B., de Oliveira, R. B., Rosa, C. A., Borelli, B. M., et al. (2018) · Infectious Disorders - Drug Targets · doi:10.2174/1871526518666180531101605 · Cited by 11
Bataineh, M. T. A., Soares, N. C., Semreen, M. H., Cacciatore, S., Dash, N. R., Hamad, M., Mousa, M., Salam, J. S. A., Gharaibeh, M. F. A., Zerbini, L. F., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259588 · Cited by 11
Perencevich, E. N., Harris, A. D., Kaye, K. S., Bradham, D. D., Fisman, D. N., Liedtke, L. A., Strausbaugh, L. J., & Infectious Diseases Society of America Emerging Infections Network (2005) · Clinical Infectious Diseases · doi:10.1086/498116 · Cited by 11
Recent patents in antifungal agent discovery
Santo, R. D. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.3.275 · Cited by 11
Anidulafungin: a drug evaluation of a new echinocandin
Joseph, J., Kim, R., & Reboli, A. C. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.13.2339 · Cited by 11
Goff, D. A., & Sierawski, S. J. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.9.748.34068 · Cited by 11
Central Venous Catheter Infections: Clinical Aspects of Microbial Etiology and Pathogenesis
Krzywda, E. A., & Edmiston, C. E. (2002) · Journal of Infusion Nursing · doi:10.1097/00129804-200201000-00006 · Cited by 11
Epidemiology of adult candidemia at Chiang Mai University Hospital.
Chaiwarith, R., Ounbang, P., Khamwan, C., Nuntachit, N., Sirisanthana, T., & Supparatpinyo, K. (2011) · PubMed · Cited by 10
Synergistic Antifungal Activity of Magnoliae Cortex and Syzyii Flos against Candida albicans
Jeemin, Y. O. O. N., & Kim, T. (2021) · Journal of the Korean Wood Science and Technology · doi:10.5658/wood.2021.49.2.142 · Cited by 10
Blood culture results during the period 1995-2002 in a Greek tertiary care hospital
Hadziyannis, A., Stefanou, I., Dimarogona, K., Pantazatou, A., Φούρκας, Δ., Filiagouridis, D., & Avlami, A. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00916.x · Cited by 10
Epidemiología de las fungemias en un hospital pediátrico de alta complejidad
Santos, P. E., Córdoba, S. B., Carrillo‐Muñoz, A. J., Rodero, L., Rubeglio, E., & Soria, M. A. (2010) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2010.07.002 · Cited by 10
Clinical Syndromes of Device-Associated Infections
Sammons, J. S., & Gerber, J. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00100-6 · Cited by 10
Nyasulu, P. S., Murray, J., Perovic, O., & KOORNHOF, H. J. (2017) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.7159 · Cited by 10
Szilágyi-Tolnai, E., Fidler, G., Szász, R., Rejtő, L., Nwozor, K. O., Bíró, S., & Paholcsek, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-73556-5 · Cited by 10
Synthesis and anticandidal evaluation of new benzothiazole derivatives with hydrazone moiety
Yurttaş, L., Kaplancıklı, Z. A., Göğer, G., & Demirci, F. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1060481 · Cited by 10
Hanberger, H., Monnet, D. L., & Nilsson, L. E. (2005) · Springer eBooks · doi:10.1007/0-387-22852-7_15 · Cited by 10
Bertrand, X., Lallemand, S., Thouverez, M., Boisson, K., & Talon, D. R. (2002) · Pathologie Biologie · doi:10.1016/s0369-8114(02)00347-4 · Cited by 10
Bouza, E., Burillo, A., & Muñóz, P. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2007.12.002 · Cited by 10
Multidrug resistance in bacterial isolates from blood cultures of haematology patients
Wróblewska, M., Marchel, H., & Łuczak, M. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00002-x · Cited by 10
Pharmacotherapy of Candida bloodstream infections: new treatment options, new era
Lewis, R. E. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.8.1039 · Cited by 10
Taverna, C. G., Córdoba, S. B., Isla, G., Fernández, N., García, S. D., Mazza, M., Murisengo, O. A., Vivot, W., Szusz, W., Davel, G., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00167-12 · Cited by 10
Ramirez, M., Serrano, M. C., Castro, C., López, E., Almeida, C., Fernández, A., Romero, A., & Martín-Mazuelos, E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl335 · Cited by 10
Pemán, J., & Almirante, B. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13128779 · Cited by 10
Zilkens, K. W., Niedhart, C., Niethard, F.-U., & Miltner, O. (2004) · Der Orthopäde · doi:10.1007/s00132-003-0594-z · Cited by 10
Sepsis and treatment-induced immunosuppression in the patient with cancer
Reigle, B. S., & Dienger, M. J. (2003) · Critical Care Nursing Clinics of North America · doi:10.1016/s0899-5885(02)00038-2 · Cited by 10
Lefort, A., Mainardi, J., Tod, M. M., & Lortholary, O. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70298-4 · Cited by 10
Maharaj, A. R., Zelenitsky, S. A., & Vercaigne, L. M. (2008) · Hemodialysis International · doi:10.1111/j.1542-4758.2008.00279.x · Cited by 10
Rosato, A. E., Tallent, S. M., Edmond, M. B., & Bearman, G. M. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.06.002 · Cited by 10
Self-citationRisk factors of nosocomial bloodstream infections in surgical intensive care unit.
Zhang, X., Tong, M., Zhang, M., & Zhu, H. (2015) · PubMed · Cited by 9
An essential protease, FtsH , influences daptomycin resistance acquisition inEnterococcus faecalis
Nair, Z. J., Gao, I. H., Firras, A., Chong, K. K. L., Hill, E. D., Choo, P. Y., Colomer‐Winter, C., Chen, Q., Manzano, C., Pethe, K., et al. (2024) · Molecular Microbiology · doi:10.1111/mmi.15253 · Cited by 9
Sengupta, P. (2024) · ACS symposium series · doi:10.1021/bk-2024-1472.ch012 · Cited by 9
Poreddy, S., Gundluru, M., Sarva, S., Pothuraju, S., Bellala, P., Konidala, K. K., Yeguvapalli, S., & Reddy, C. S. (2024) · Organic Communications · doi:10.25135/acg.oc.172.24.07.3269 · Cited by 9
Quinolone Resistance and Its Clinical Relevance
Low, D. E. (2014) · ASM Press eBooks · doi:10.1128/9781555817817.ch23 · Cited by 9
Resistance to Antifungal Agents
Arthington, B. A., & Rex, J. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-72418-8_10 · Cited by 9
Candidaemia in a tertiary hospital in Nigeria
Oladele, R. O., Bakare, R. A., Petrou, M. A., Oduyebo, O. O., & Richardson, M. D. (2014) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v3i1.89 · Cited by 9
Essential Oils for the Prevention and Treatment of Human Opportunistic Fungal Diseases
Marković, T., Nikolić, M., Glamočlija, J., Ćirić, A., Emerald, M., Radanović, D., Zheljazkov, V. D., & Sokóvić, M. (2016) · ACS symposium series · doi:10.1021/bk-2016-1218.ch015 · Cited by 9
Akbari, S., Bayat, M., Roudbarmohammadi, S., & Hashemi, J. (2019) · Periodica Polytechnica Chemical Engineering · doi:10.3311/ppch.12519 · Cited by 9
Rizzo, S., Vito, M. D., Mazzinelli, E., Favuzzi, I., Torelli, R., Cacaci, M., Arcovito, A., Sanguinetti, M., Garzoli, S., Nocca, G., et al. (2023) · Plants · doi:10.3390/plants12132437 · Cited by 9
Al-Hazmi, H. H., Alzahrani, T., & El-Malky, A. M. (2014) · Saudi Journal of Anaesthesia · doi:10.4103/1658-354x.144084 · Cited by 9
Serrano, R., Gimeno, A., Plumed, L., Pemán, J., Álvarez, B., Plazas, J., & Caturla, J. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.06.003 · Cited by 9
Obolski, U., Alon, D., Hadany, L., & Stein, G. Y. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku156 · Cited by 9
Metabolic adaptation via regulated enzyme degradation in the pathogenic yeast Candida albicans
Ting, S. Y., Ishola, O. A., Ahmed, M. A., Tabana, Y., Dahham, S. S., Agha, M. T., Musa, S. F., Muhammed, R., Than, L. T. L., & Sandai, D. A. (2016) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2016.12.002 · Cited by 9
Grand, M., Blancato, V. S., Espariz, M., Deutscher, J., Pikis, A., Hartke, A., Magni, C., & Sauvageot, N. (2019) · Molecular Microbiology · doi:10.1111/mmi.14431 · Cited by 9
Non-contiguous multifocal vertebral osteomyelitis caused bySerratia marcescens
Lau, J. X., Li, J. Y. Z., & Yong, T. Y. (2014) · Modern Rheumatology · doi:10.3109/14397595.2013.874754 · Cited by 9
Taniguchi, T., Ogawa, Y., Kasai, D., Watanabe, D., Yoshikawa, K., Bando, H., Yajima, K., Tominari, S., Shiiki, S., Nishida, Y., et al. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.3811 · Cited by 9
Özkaya, E., Tümer, S., Kirişçi, Ö., Çalışkan, A., & Erdoğmuş, P. (2015) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2015.49260 · Cited by 9
Empiric antifungal therapy in neutropenic cancer patients
Rotstein, C. (2006) · Current Infectious Disease Reports · doi:10.1007/s11908-006-0029-1 · Cited by 9
Resistance Surveillance in Italy: Four-Year Results from the MYSTIC Program
Fontana, R., Cascio, G. L., Giacobone, E., Romero, E., Cipriani, P., Sessa, R., & Franchino, L. (2002) · Journal of Chemotherapy · doi:10.1179/joc.2002.14.4.323 · Cited by 9
Beta-Lactam Resistance: Clinical Implications for Pediatric Patients
Dajani, A. S. (2002) · Journal of International Medical Research · doi:10.1177/14732300020300s102 · Cited by 9
Miyamoto, H., Imamura, K., Kojima, A., Takenaka, H., Hara, N., Ikenouchi, A., Tanabe, T., & Taniguchi, H. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1374 · Cited by 9
Bloodstream Infection and Endocarditis
Seifert, H., & Wisplinghoff, H. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0019 · Cited by 9
Metadata
- Authors
- Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Wenzel, Richard P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08
- Volume
- 29
- Issue
- 2
- Pages
- 239-244
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2157766752
- Cited by
- 1,387
- References
- 16
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 13 · 2023: 13 · 2022: 18 · 2021: 21 · 2020: 23 · 2019: 37 · 2018: 31 · 2017: 36 · 2016: 41 · 2015: 33 · 2014: 56 · 2013: 55 · 2012: 55
- FWCI
- 47.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- nosocomial bloodstream infection, hospital-acquired bacteremia, coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus, Gram-positive bacteria, Gram-negative bacteria, fungemia, methicillin resistance, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, Streptococcus viridans, neutropenia, intensive care unit, empirical antibiotic therapy, infection surveillance
- MeSH terms
- Candida, Cross Infection, Gram-Negative Bacteria, Gram-Positive Bacteria, Hospitals, Humans, Neutropenia, Staphylococcus, United States, Fungemia, Bacteremia, Enterococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.